Hepatocellular Carcinoma (HCC): An Update
- 30 April 2007
- journal article
- review article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 34, S12-S20
- https://doi.org/10.1053/j.seminoncol.2007.01.007
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 2005
- Molecular-based prediction of early recurrence in hepatocellular carcinomaJournal of Hepatology, 2004
- Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factorJournal of Hepatology, 2004
- Differential expression of somatostatin receptor subtypes in hepatocellular carcinomasJournal of Hepatology, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Is surgery for large hepatocellular carcinoma justified?Journal of Hepatology, 1999
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990